Catalyst Wire Dossier Catalyst Wire Dossier

NAFT-500

· Merz North America, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NAFT-500, covering 2012-03-13 to 2013-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Pedis [Phase 3]

See pricing